Columna Capital completed the acquisition of a minority stake in Physidia.

Columna Capital, an investment firm, completed the acquisition of a minority stake in Physidia, a home haemodialysis solutions provider. Financial terms were not disclosed. “Our commitment to continuously evolving technology developments can help to shift notoriously debilitating, life-disruptive diagnoses into manageable outcomes and better quality of life – changing the experience of dialysis for patients across Europe. This strategic partnership with Columna will allow us to widen the reach of our existing products and services, while also making a meaningful expansion into international markets," Didier Candelot, Physidia CEO.